Astellas Pharma Inc (OTCPK:ALPMF)
$ 11.095 -0.0325 (-0.29%) Market Cap: 19.93 Bil Enterprise Value: 24.15 Bil PE Ratio: 54.12 PB Ratio: 2.00 GF Score: 82/100

Q3 2023 Astellas Pharma Inc Earnings Presentation Transcript

Feb 06, 2023 / NTS GMT
Release Date Price: $14.35 (-1.07%)

Feb 06, 2023 / NTS GMT
Presentation
Feb 06, 2023 / NTS GMT

=====================
Corporate Participants
=====================
* Hiromitsu Ikeda
Astellas Pharma Inc. - Corporate Head of Advocacy & Relations
* Kenji Yasukawa
Astellas Pharma Inc. - President, CEO & Chairman of the Board
* Minoru Kikuoka
Astellas Pharma Inc. - CFO & Senior Managing Executive Officer
* Naoki Okamura
Astellas Pharma Inc. - Executive VP, Chief Strategy Officer & Representative Director
* Tadaaki Taniguchi
Astellas Pharma Inc. - Chief Medical Officer
* Yukio Matsui
Astellas Pharma Inc. - Chief Commercial Officer & Senior Corporate Executive

=====================
Conference Call Participants
=====================
* Akinori Ueda
Goldman Sachs Group, Inc., Research Division - Equity Analyst
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Kazuaki Hashiguchi
Daiwa

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot